Raymond James Downgrades Meridian Biosciences (VIVO) to Underperform
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $33.97 --0%
Rating Summary:
3 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
3 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Raymond James downgraded Meridian Biosciences (NASDAQ: VIVO) from Market Perform to Underperform.
For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.
Shares of Meridian Biosciences closed at $16.46 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Synovus Financial (SNV) to Market Perform
- Wells Fargo Downgrades Sunnova (NOVA) to Equal Weight
- Stifel Canada Downgrades Saipem (SPM:IM) (SAPMF) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
